Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
Maria Pinkerneil(Heinrich Heine University Düsseldorf), Günter Niegisch(German Cancer Research Center)
Cited by 57
Related Papers
HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition
|International Journal of Molecular Sciences|2019|19
Evaluation of <scp>HER2</scp> expression in urothelial carcinoma cells as a biomarker for circulating tumor cells
|Cytometry Part B Clinical Cytometry|2020|16
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
|Journal of Experimental & Clinical Cancer Research|2014|1